Supplying 'OncoStudio' to the University of Chicago Medical Center, advancing global clinical application
Oncosoft, a medical artificial intelligence (AI) solution company, announced on the 5th that it has been selected as a supplier for the '2025 AI Voucher Support Program (Global Division),' organized by the Ministry of Science and ICT (MSIT) and the National IT Industry Promotion Agency (NIPA).
The company explained that this marks the third consecutive year it has been named in the program, following 2023 and 2024, solidifying its position as a leading company in the medical AI field.
The AI Voucher Support Program (Global Division), run by the MSIT and NIPA, is a program designed to support the overseas market entry of promising AI companies that have proven their technological capabilities in Korea.
Through this program, Oncosoft will install its AI-based auto-contouring software, 'OncoStudio,' at the University of Chicago Medical Center in the United States and will proceed with global clinical validation.
OncoStudio is a solution that automates the process of contouring human organs, a key step in radiation therapy planning, to support rapid and precise treatment planning. Based on a patient-specific algorithm, the software accurately recognizes the individual's anatomy and automatically outlines the treatment target organs and major tissues.
According to the company, since receiving approval from the Korean Ministry of Food and Drug Safety in 2022, the solution has been introduced in over 20 university hospitals, proving its clinical effectiveness and safety. Recently, it has also obtained U.S. FDA clearance and Japanese medical device certification, officially recognizing its global competitiveness.
Oncosoft CEO Kim Jinsung stated, "Our selection as an AI voucher supplier once again recognizes our technological capabilities and clinical experience." He added, "We will continue to accelerate the global expansion of our AI radiation therapy solutions that realize patient-customized precision medicine through cooperation with domestic and international medical institutions."
